6 Pharma Trends for 2025: Trump’s Return, AI Breakthroughs, and Market Access Challenges
Pharma is facing a new set of launch, market access and strategic challenges as the pandemic has changed some market characteristics for good.
An agile launch execution platform, with full visibility across countries and
functions.
A collaborative platform for teams who plan reimbursements and HTA activities.
A collaborative platform designed to manage pharmaceutical tenders across
countries.
A capability management platform that unifies capabilities, resources, and assessment.
Manage your entire pipeline. Track every move. Stay ahead, from discovery to launch.
Our products
Andre Moa
21 Jan 2025
21 minute read
Pharma is facing a new set of launch, market access and strategic challenges as the pandemic has changed some market characteristics for good.
6 of our key pharma trends that will shape the industry are illustrated on our pharma trends for 2018 infographic.
Value, innovation, inter-connectivity, personalisation, and the disruptive impact of digital tools and online retail: these are key pharma trends for 2018.
Effective and proactive tender management is critical to capitalising on new growth opportunities for pharmaceuticals and vaccines worldwide.
A smart business tool can save you time to optimise efficiency and market access in a pharma sector swamped with data, communications and multiple inputs.
Close attention to launch timelines and status will help save you from stumbling at the final hurdle to successful pharma market entry.
Making the most of pharma launch planning includes ensuring that launch team members are focused on strategic objectives, not data collection and processing.
A launch readiness framework is a must to handle pharma market access challenges. You need the tools to ensure a living framework is embedded enterprise wide.
Damaging constraints on patient access to medicines come from many quarters. Pharma companies must ensure that poorly co-ordinated and executed drug launches are not to blame.
Today’s launch strategies are more modestly scaled, but they must be planned, implemented and tracked in greater depth.
There is plenty of pharmaceutical innovation left in the tank, judging by current product pipelines. Pharma launch challenges, though, have never been tougher.
From pricing concerns, reputational damage control, Trumpian uncertainty, technology convergence to multichannel, we predict the key pharma trends for 2017.
Pharmaceutical companies must ensure that each component of their product launch plan makes a meaningful contribution to return on investment (ROI).
TRiBECA Knowledge needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Notice.